For anyone who may be curious to try dipping their toes into the world of psychedelic mushrooms, one of the first and most common questions one might ask is, “How long do shrooms last?” It’s a natural question, given the anxious anticipation that can preempt any psychedelic excursion, and definitely one that bears a bit of research before embarking on a virgin magic mushroom voyage.

Good news from the Australian Therapeutic Goods Administration, as they will now allow for the prescription of MDMA to treat post-traumatic stress disorder (PTSD), and psilocybin to combat treatment-resistant depression. This new classification is a step forward in providing relief with alternative treatments that have been proven effective.

In this episode, David Flores sits down with Cannara CFO Nicholas Sosiak, to discuss the Company's future goals and to spotlight what differentiates Cannara from other companies in the cannabis space.